The use of aspirin to prevent the first occurrence of cardiovascular disease (i.e. so-callled “primary prevention”) is a controversial area. Still, a consensus seems to have emerged that aspirin should be given to prevent CV disease, but only in those people who are at least at moderately increased risk of CV disease compared to the rest of the population. Of course, this is where the controversy has now shifted - what is ‘at least moderately increased risk’ and how is it recognized?
The American Heart Association guidelines for primary prevention recommend aspirin prophylaxis in all individuals with a 10-year risk of CV disease of 10 percent or more (this is their ad hoc definition of “at least moderately increased risk”). How is such risk determined? By using the Framingham risk score.
In the UK and Ireland ( and possibly the rest of europe, I don’t know) the standard “low-dose” aspirin for primary and secondary prevention is *not * 81mg- it’s 75mg.
81 mg is almost exactly 1.25 grains - a grain is 1/7000 pound. I suspect aspirin doses in the U.S. were originally measured in grains, and that the standard doses were kept about the same size when manufacturers converted to metric units.